This one looked over.
The Ottawa Senators were staring a three-game deficit right in the face, down a goal with 90 seconds to go. Then, to make matters worse, Erik Karlsson took a slashing penalty, putting them down a man as well. But the Senators refused to go away, and a minute into the...
Florida Gulf Coast advanced within a victory of the NCAA tournament last season and this season, but the unheralded upstarts that played in the Atlantic Sun title game last March bore only faint resemblance to the confident team that took the floor Saturday.
When the sixth-seeded Eagles...
Eric Fehr finds his way through, we swear.
There haven't been a lot of highlights for the Washington Capitals this season. If things don't turn around, Tuesday night's game against the Boston Bruins will at least make fans smile when they remember this season before quickly moving on to the...
Six races into the 2012 season, Kasey Kahne was ranked 31st in the Sprint Cup standings, and his much-anticipated Hendrick Motorsports debut appeared to be on the verge of a Year One bust.
Funny what two wins and a bit of talent will do for a guy.
Three months after that Martinsville race...
Company has prototyped a new software architecture for automating data management, potentially making it easier for researchers to collect usable information from mega-scale data collection projects like the Square Kilometre Array (SKA) global telescope which aims to address unanswered...
Airbus, one of the world's largest aircraft manufacturers, has doubled its usable supercomputing power with containerized HP Performance Optimized Datacenters (PODs).
It was four years in the making, but for Michigan State's Arthur Ray Jr., the wait was worth it. After battling cancer for much of his college career, Ray stepped onto the field at Spartan Stadium for the first time in the Spartans' 28-6 win over Youngstown State on Friday night. He was a...
Team Penske dominated the IndyCar Series race at Sonoma to give Roger Penske his first weekend with both a NASCAR Sprint Cup and IndyCar win since 2000.
On June 19, 2000, it was Jeremy Mayfield at Pocono and Helio Castroneves at Belle Isle in Detroit. Saturday night it was Brad Keselowski and...
Pharmaceutics International, Inc. (Pii), a leading contract development and manufacturing organization, today announced it has successfully completed the first-ever US-based joint European Medicines Agency (EMA) and Food and Drug Administration (FDA) inspection. "Our entire team is very proud...
Johnson & Johnson (NYSE: JNJ) announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke. Johnson & Johnson announced its agreement to acquire Micrus on July 12, 2010. Micrus...
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced the Phase I clinical study assessing Inovio's PENNVAX™-B DNA vaccine delivered using its proprietary electroporation technology in...
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg...
Business telecommunications provider, Digital Island, has completed pilot and is now offering 3G business mobile services based on Telecom New Zealand's wholesale mobile network.
Endo Pharmaceuticals (Nasdaq: ENDP) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The...
PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic...
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with...
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease...
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease...